Currently, selective PDE inhibitors have been investigated for the treatment of a wide range of diseases, such as chronic obstructive pulmonary disease (COPD), asthma, pulmonary hypertension and erectile dysfunction etc [19]. The gene discussed is ALDH7A1; the disease is pulmonary hypertension.